Staniuk Tomasz, Zegarski Wojciech, Małkowski Bogdan, Jankowski Michał, Klag Michał, Pietrzak Tomasz
Oncology Centre - Prof. Lukaszczyk Memorial Hospital, Bydgoszcz, Poland.
Contemp Oncol (Pozn). 2013;17(2):165-70. doi: 10.5114/wo.2013.34621. Epub 2013 Apr 29.
Evaluation of FLT/PET/ CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer.
The FLT/PET/CT test was carried out in a group of 50 gastric cancer patients. Based on the test result, a decision followed about the therapeutic procedure to be applied. A comparison was made with regards to the consistency of the cancer growth advancement degree evaluation in the initial preoperative FLT/PET/CT test against the evaluation of postoperative degree of cancer advancement in histopathology.
In the group of 50 diagnosed patients a surgical treatment was used for 37 patients. 21 resections were performed out of which 19 operations were radical In the group of 16 non-resective operations 2 post-laparotomic patients were selected for inductive treatment. In the group of 13 patients who did not undergo any surgery, 10 were directed to palliative care and 3 for inductive treatment. In the group of 50 patients, the applied FLT-PET/CT test confirmed presence of primary tumor in 49 patients. The presence of increased uptake of FLT in the local lymph nodes during the preoperative FLT-PET/CT test was confirmed in 22 cases. In 14 patients with FLT-PET/Ct N(+) with the M(-) feature resection surgery was performed. The increased uptake of FLT in localizing metastases (nodal and non-nodal) FLT-PET/CT (M+) was detected in 22 patients. The presence of nodal metastases in the postoperative histopathology examination (hpN+) was detected in 14 cases. In these cases preoperative FLT-PET/CT test proved the N(+) feature in 11 patients. The result FLT-PET/CT N(-) was truly negative in 2 patients, and false negative in 1 patient. In the group of 7 operated hpN(-) patients, in 3 patients a preoperative result FLT-PET/ CT N(+) (false positive result) was obtained. The consistency (positive) of nodal metastases identification in FLT-PET/CT as compared to post-surgical histopathology examination scored 11/15, which equals 73.3%. In the group of patients in whom resection surgery was performed, 4 false negative results were obtained [hp(N+), FLT-PET/CT (N-)] and 3 false positive results [hp(N-), FLT-PET/CT N(+)].
The initial test results indicate that FLT-PET/CT is an effective method in evaluating the primary tumor and the regional lymph nodes and is useful and beneficial in the diagnosis and further treatment evaluation of gastric cancer. FLT-PET/CT examination facilitates making proper therapeutic decisions - it allows the number of unnecessary laparotomies to be lowered.
评估氟代胸苷(FLT)/正电子发射断层显像(PET)/计算机断层扫描(CT)在胃癌诊断及手术治疗资格判定中的应用价值。
对50例胃癌患者进行了FLT/PET/CT检查。根据检查结果决定采用何种治疗方案。将术前初始FLT/PET/CT检查中对癌生长进展程度的评估与术后病理组织学检查中癌进展程度的评估进行一致性比较。
在50例确诊患者中,37例行手术治疗。其中21例行切除术,19例为根治性手术。在16例非切除手术患者中,2例剖腹术后患者被选进行诱导治疗。在13例未接受任何手术的患者中,10例接受姑息治疗,3例接受诱导治疗。在50例患者中,所应用的FLT-PET/CT检查证实49例存在原发性肿瘤。术前FLT-PET/CT检查证实22例局部淋巴结中FLT摄取增加。对14例FLT-PET/Ct显示N(+)且M(-)特征的患者进行了切除手术。22例患者在FLT-PET/CT检查中发现转移灶(淋巴结及非淋巴结)中FLT摄取增加(M+)。术后病理组织学检查(hpN+)发现14例存在淋巴结转移。在这些病例中,术前FLT-PET/CT检查证实11例为N(+)特征。FLT-PET/CT检查结果为N(-)的2例为真阴性,1例为假阴性。在7例手术治疗且hpN(-)的患者中,3例术前FLT-PET/CT检查结果为N(+)(假阳性结果)。与术后病理组织学检查相比,FLT-PET/CT检查中淋巴结转移识别的一致性(阳性)为11/15,即73.3%。在接受切除手术的患者组中,获得4例假阴性结果[hp(N+),FLT-PET/CT(N-)]和3例假阳性结果[hp(N-),FLT-PET/CT N(+)]。
初始检查结果表明,FLT-PET/CT是评估原发性肿瘤和区域淋巴结的有效方法,在胃癌诊断及进一步治疗评估中有用且有益。FLT-PET/CT检查有助于做出正确的治疗决策——可减少不必要的剖腹手术数量。